VIM and neoplasm: Percentages of vimentin-positive cells greatly varied, ranging from <10% (eight EcPV2+ and five EcPV2− tumors), and <50% (two EcPV2+ and five EcPV2− tumors), to >50% (EcPV2+ tumor KLU, and EcPV2− tumor FIL) (Table 2).